Mai F. Tolba

Ain Shams University

H指数:23

被引数:1,647

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Simvastatin Mitigates Chemotherapy-Induced Depressive-Like Behaviors in Rats

辛伐他汀减轻化疗诱导的抑郁样行为在大鼠中的表现

Archiv der Pharmazie

IF3.6

2026-10-050

PRE

Trimetazidine protects against doxorubicin-induced chemobrain in rats: Insights into energy imbalance and neuroinflammation

曲美他嗪对多柔比星诱导的大鼠化疗脑具有保护作用：对能量失衡和神经炎症的见解

European Journal of Pharmacology

IF4.7

2025-11-060

PRE

The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies

CDK4/6抑制剂在实体恶性肿瘤中的治疗格局：强调免疫治疗联合策略

Medical Oncology

IF3.5

2025-08-260

OAAI

In vivo modulation of the tumor microenvironment: anti-tumor effects of combination therapy of fucoidan and small molecule immune checkpoint inhibitor BMS-202

体内调节肿瘤微环境：岩藻黄质与小分子免疫检查点抑制剂BMS-202联合疗法的抗肿瘤作用

International Immunopharmacology

IF4.7

2025-07-250

PRE

Trimetazidine mitigates methotrexate-induced liver damage: Insights From biochemical, histological, and in silico analyses

曲美他嗪减轻甲氨蝶呤诱导的肝损伤：来自生化、组织学和计算机分析的见解

ARCHIV DER PHARMAZIE

IF3.6

2025-04-010

PRE

In silico and In vivo protective effect of biochanin-A mitigating doxorubicininduced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132

NEUROTOXICOLOGY

IF3.9

2025-03-010

PRE

Insights into the therapeutic outcomes of trimetazidine/doxorubicin combination in Ehrlich solid-phase carcinoma mouse tumor model

LIFE SCIENCES

IF5.1

2023-09-014

PRE

The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model

PHYTOTHERAPY RESEARCH

IF6.3

2022-02-0218

PRE

The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2022-01-0120

PRE

Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer

免疫疗法是治疗乳腺癌的一种不断发展的方法

FRONTIERS IN ONCOLOGY

IF3.3

2021-11-242

OAAI

SARS-CoV-2 Viral Shedding and Transmission Dynamics: Implications of WHO COVID-19 Discharge Guidelines

FRONTIERS IN MEDICINE

IF3

2021-06-1732

OAAI

The impact of NF-κB inhibition on the sensitivity of breast cancer cells to chemotherapy-induced apoptosis

CANCER RESEARCH

IF16.6

2020-08-150

PRE

Revolutionizing the landscape of colorectal cancer treatment: The potential role of immune checkpoint inhibitors

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2020-06-0150

OAAI

Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment

癌症中的免疫调节microrna: 靶向免疫检查点和肿瘤微环境

FEBS JOURNAL

IF4.2

2019-07-2768

OAAI

The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2019-05-0115

PREAI

Tackling molecular targets beyond PD-1/PD-L1: Novel approaches to boost patients' response to cancer immunotherapy

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2019-03-0125

PREAI

Caffeic acid phenethyl ester guards against benign prostate hypertrophy in rats: Role of IGF-1R/protein kinase-B (Akt)/β-catenin signaling

IUBMB LIFE

IF3.2

2018-03-309

OAAI

Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

IF5.6

2018-02-0152

PREAI

The impact of catechol estrogen metabolism on the proliferation rate and Docetaxel (DOC) resistance in hormone-responsive cancers

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Caffeic acid phenethyl ester protects against glucocorticoid-induced osteoporosis in vivo: Impact on oxidative stress and RANKL/OPG signals

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2017-06-0158

PREAI

Mai F. Tolba

个人简介

教育背景

工作经历

荣誉奖项

研究方向